Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Lin, Yuan Ta ^a,b   Chern, Yijuang ^c   Shen, Che Kun James ^b   Wen, Hsin Lan ^b   Chang, Ya Chin ^d   Li, Hung ^a,b   Cheng, Tzu Hao ^a   Hsieh Li, Hsiu Mei ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CHEMOKINE RECEPTOR CXCR4; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; QUINOLINIC ACID; STROMAL CELL DERIVED FACTOR 1; VON WILLEBRAND FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORPUS STRIATUM; HOST CELL; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROGLIA; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE; NERVE CELL DIFFERENTIATION; NEUROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; ANIMAL; BONE MARROW TRANSPLANTATION; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL MOTION; CYTOLOGY; DISEASE MODEL; DRUG EFFECT; MESENCHYMAL STEM CELL; METABOLISM; MOTONEURON; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; MUS;

ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; CASPASE 3; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; HUNTINGTON DISEASE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICROGLIA; MOTOR NEURONS; QUINOLINIC ACID;

EID: 79961147771     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022924     Document Type: Article

References (71)

1. Kremer B, Goldberg P, Andrew SE, Theilmann J, Telenius H, et al. (1994) A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med 330: 1401-1406.
2. Rubinsztein DC, Amos W, Leggo J, Goodburn S, Ramesar RS, et al. (1994) Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence. Nat Genet 7: 525-530.
3. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, et al. (1985) Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 44: 559-577.
4. Ramaswamy S, Shannon KM, Kordower JH, (2007) Huntington's disease: pathological mechanisms and therapeutic strategies. Cell Transplant 16: 301-312.
5. Bachoud-Levi AC, Remy P, Nguyen JP, Brugieres P, Lefaucheur JP, et al. (2000) Motor and cognitive improvements in patients with Huntington's disease after neural transplantation. Lancet 356: 1975-1979.
6. Keene CD, Sonnen JA, Swanson PD, Kopyov O, Leverenz JB, et al. (2007) Neural transplantation in Huntington disease: long-term grafts in two patients. Neurology 68: 2093-2098.
7. Bjorklund A, (1993) Neurobiology. Better cells for brain repair. Nature 362: 414-415.
8. Shen LH, Li Y, Chen J, Zhang J, Vanguri P, et al. (2006) Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke. Neuroscience 137: 393-399.
9. Prockop DJ, Azizi SA, Colter D, Digirolamo C, Kopen G, et al. (2000) Potential use of stem cells from bone marrow to repair the extracellular matrix and the central nervous system. Biochem Soc Trans 28: 341-345.
10. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, et al. (2004) Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113: 1701-1710.
11. Jin HK, Carter JE, Huntley GW, Schuchman EH, (2002) Intracerebral transplantation of mesenchymal stem cells into acid sphingomyelinase-deficient mice delays the onset of neurological abnormalities and extends their life span. J Clin Invest 109: 1183-1191.
12. Torrente Y, Polli E, (2008) Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 17: 1103-1113.
13. Shyu WC, Lin SZ, Chiang MF, Su CY, Li H, (2006) Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats. J Neurosci 26: 3444-3453.
14. Snyder BR, Chiu AM, Prockop DJ, Chan AW, (2010) Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease. PLoS One 5: e9347.
15. Shyu WC, Liu DD, Lin SZ, Li WW, Su CY, et al. (2008) Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. J Clin Invest 118: 2482-2495.
16. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ, (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci U S A 102: 18171-18176.
17. Chindewa R, Lapanantasin S, Sanvarinda Y, Chongthammakun S, (2008) Pueraria mirifica, phytoestrogen-induced change in synaptophysin expression via estrogen receptor in rat hippocampal neuron. J Med Assoc Thai 91: 208-214.
18. Hayase M, Kitada M, Wakao S, Itokazu Y, Nozaki K, et al. (2009) Committed neural progenitor cells derived from genetically modified bone marrow stromal cells ameliorate deficits in a rat model of stroke. J Cereb Blood Flow Metab 29: 1409-1420.
19. Zand L, Ryu JK, McLarnon JG, (2005) Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus. Neuroreport 16: 129-132.
20. Stumm RK, Zhou C, Ara T, Lazarini F, Dubois-Dalcq M, et al. (2003) CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 23: 5123-5130.
21. Yanagawa Y, Iwabuchi K, Onoe K, (2001) Enhancement of stromal cell-derived factor-1alpha-induced chemotaxis for CD4/8 double-positive thymocytes by fibronectin and laminin in mice. Immunology 104: 43-49.
22. Hernandez-Lopez C, Valencia J, Hidalgo L, Martinez VG, Zapata AG, et al. (2008) CXCL12/CXCR4 signaling promotes human thymic dendritic cell survival regulating the Bcl-2/Bax ratio. Immunol Lett 120: 72-78.
23. Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, et al. (2007) Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9: 862-870.
24. Wendt MK, Drury LJ, Vongsa RA, Dwinell MB, (2008) Constitutive CXCL12 expression induces anoikis in colorectal carcinoma cells. Gastroenterology 135: 508-517.
25. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
26. Lescaudron L, Unni D, Dunbar GL, (2003) Autologous adult bone marrow stem cell transplantation in an animal model of huntington's disease: behavioral and morphological outcomes. Int J Neurosci 113: 945-956.
27. Alberti E, Los M, Garcia R, Fraga JL, Serrano T, et al. (2009) Prolonged survival and expression of neural markers by bone marrow-derived stem cells transplanted into brain lesions. Med Sci Monit 15: BR47-54.
28. Sadan O, Shemesh N, Barzilay R, Bahat-Stromza M, Melamed E, et al. (2008) Migration of neurotrophic factors-secreting mesenchymal stem cells toward a quinolinic acid lesion as viewed by magnetic resonance imaging. Stem Cells 26: 2542-2551.
29. Chamberlain G, Fox J, Ashton B, Middleton J, (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749.
30. Amin EM, Reza BA, Morteza BR, Maryam MM, Ali M, et al. (2008) Microanatomical evidences for potential of mesenchymal stem cells in amelioration of striatal degeneration. Neurol Res 30: 1086-1090.
31. Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M, (2010) Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum. Neurol Res 32: 166-172.
32. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, et al. (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214: 193-200.
33. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, et al. (2010) Open-labeled study of unilateral autologous bone-marrow-derived mesenchymal stem cell transplantation in Parkinson's disease. Transl Res 155: 62-70.
34. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, et al. (1986) Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 321: 168-171.
35. Sanberg PR, Coyle JT, (1984) Scientific approaches to Huntington's disease. CRC Crit Rev Clin Neurobiol 1: 1-44.
36. McBride JL, Behrstock SP, Chen EY, Jakel RJ, Siegel I, et al. (2004) Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. J Comp Neurol 475: 211-219.
37. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, et al. (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214: 193-200.
38. Dusart I, Marty S, Peschanski M, (1991) Glial changes following an excitotoxic lesion in the CNS-II. Astrocytes. Neuroscience 45: 541-549.
39. Shin JY, Fang ZH, Yu ZX, Wang CE, Li SH, et al. (2005) Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 171: 1001-1012.
40. Acarin L, Gonzalez B, Castellano B, (2000) Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci 12: 3505-3520.
41. Marco S, Canudas AM, Canals JM, Gavalda N, Perez-Navarro E, et al. (2002) Excitatory amino acids differentially regulate the expression of GDNF, neurturin, and their receptors in the adult rat striatum. Exp Neurol 174: 243-252.
42. Strauss S, Otten U, Joggerst B, Pluss K, Volk B, (1994) Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Neurosci Lett 168: 193-196.
43. Li WY, Choi YJ, Lee PH, Huh K, Kang YM, et al. (2008) Mesenchymal stem cells for ischemic stroke: changes in effects after ex vivo culturing. Cell Transplant 17: 1045-1059.
44. Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, et al. (2004) Striatal neural grafting improves cortical metabolism in Huntington's disease patients. Brain 127: 65-72.
45. Hauser RA, Furtado S, Cimino CR, Delgado H, Eichler S, et al. (2002) Bilateral human fetal striatal transplantation in Huntington's disease. Neurology 58: 687-695.
46. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O, (2002) Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 8: 963-970.
47. Goings GE, Sahni V, Szele FG, (2004) Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury. Brain Res 996: 213-226.
48. Lazic SE, Grote HE, Blakemore C, Hannan AJ, van Dellen A, et al. (2006) Neurogenesis in the R6/1 transgenic mouse model of Huntington's disease: effects of environmental enrichment. Eur J Neurosci 23: 1829-1838.
49. Gil JM, Mohapel P, Araujo IM, Popovic N, Li JY, et al. (2005) Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice. Neurobiol Dis 20: 744-751.
50. Zhou FC, (1990) Four patterns of laminin-immunoreactive structure in developing rat brain. Brain Res Dev Brain Res 55: 191-201.
51. Mercier F, Kitasako JT, Hatton GI, (2002) Anatomy of the brain neurogenic zones revisited: fractones and the fibroblast/macrophage network. J Comp Neurol 451: 170-188.
52. Fuchs E, Tumbar T, Guasch G, (2004) Socializing with the neighbors: stem cells and their niche. Cell 116: 769-778.
53. Wu J, Sun Z, Sun HS, Weisel RD, Keating A, et al. (2008) Intravenously administered bone marrow cells migrate to damaged brain tissue and improve neural function in ischemic rats. Cell Transplant 16: 993-1005.
54. Amann B, Luedemann C, Ratei R, Schmidt-Lucke JA, (2009) Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 18: 371-380.
55. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, et al. (2001) Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104: 1046-1052.
56. Ohab JJ, Fleming S, Blesch A, Carmichael ST, (2006) A neurovascular niche for neurogenesis after stroke. J Neurosci 26: 13007-13016.
57. Kasper G, Dankert N, Tuischer J, Hoeft M, Gaber T, et al. (2007) Mesenchymal stem cells regulate angiogenesis according to their mechanical environment. Stem Cells 25: 903-910.
58. Tanabe S, Heesen M, Yoshizawa I, Berman MA, Luo Y, et al. (1997) Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159: 905-911.
59. Thored P, Arvidsson A, Cacci E, Ahlenius H, Kallur T, et al. (2006) Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24: 739-747.
60. Robin AM, Zhang ZG, Wang L, Zhang RL, Katakowski M, et al. (2006) Stromal cell-derived factor 1alpha mediates neural progenitor cell motility after focal cerebral ischemia. J Cereb Blood Flow Metab 26: 125-134.
61. Dasari VR, Spomar DG, Cady C, Gujrati M, Rao JS, et al. (2007) Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem Res 32: 2080-2093.
62. Jeong SW, Chu K, Jung KH, Kim SU, Kim M, et al. (2003) Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Stroke 34: 2258-2263.
63. Emerich DF, Thanos CG, Goddard M, Skinner SJ, Geany MS, et al. (2006) Extensive neuroprotection by choroid plexus transplants in excitotoxin lesioned monkeys. Neurobiol Dis 23: 471-480.
64. Kordower JH, Chen EY, Winkler C, Fricker R, Charles V, et al. (1997) Grafts of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice: trophic and tropic effects in a rodent model of Huntington's disease. J Comp Neurol 387: 96-113.
65. Krystkowiak P, Gaura V, Labalette M, Rialland A, Remy P, et al. (2007) Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease. PLoS One 2: e166.
66. Keene CD, Chang RC, Leverenz JB, Kopyov O, Perlman S, et al. (2009) A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions. Acta Neuropathol 117: 329-338.
67. Reuter I, Tai YF, Pavese N, Chaudhuri KR, Mason S, et al. (2008) Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease. J Neurol Neurosurg Psychiatry 79: 948-951.
68. Capetian P, Knoth R, Maciaczyk J, Pantazis G, Ditter M, et al. (2009) Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation. Neuroscience 160: 661-675.
69. Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, et al. (2009) Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci U S A 106: 12483-12488.
70. Lee ST, Chu K, Jung KH, Im WS, Park JE, et al. (2009) Slowed progression in models of Huntington disease by adipose stem cell transplantation. Ann Neurol 66: 671-681.
71. Lee ST, Chu K, Park JE, Hong NH, Im WS, et al. (2008) Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways. J Neurochem 104: 1190-1200.